Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell Death

Cardiac glycosides (CGs) are natural compounds used traditionally to treat congestive heart diseases. Recent investigations repositioned CGs as potential anticancer agents. To discover novel cytotoxic CG scaffolds, we selected the cardenolide glucoevatromonoside (GEV) out of 46 CGs for its low nanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Naira F. Z., Cerella, Claudia, Lee, Jin-Young, Mazumder, Aloran, Kim, Kyung Rok, de Carvalho, Annelise, Munkert, Jennifer, Pádua, Rodrigo M., Kreis, Wolfgang, Kim, Kyu-Won, Christov, Christo, Dicato, Mario, Kim, Hyun-Jung, Han, Byung Woo, Braga, Fernão C., Simões, Cláudia M. O., Diederich, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838923/
https://www.ncbi.nlm.nih.gov/pubmed/29545747
http://dx.doi.org/10.3389/fphar.2018.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838923/
https://www.ncbi.nlm.nih.gov/pubmed/29545747
http://dx.doi.org/10.3389/fphar.2018.00070

Ejemplares similares